These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 817293)

  • 21. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees.
    Kennedy RC; Eichberg JW; Lanford RE; Dreesman GR
    Science; 1986 Apr; 232(4747):220-3. PubMed ID: 3952505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human hepatitis B vaccine from recombinant yeast.
    McAleer WJ; Buynak EB; Maigetter RZ; Wampler DE; Miller WJ; Hilleman MR
    Nature; 1984 Jan 12-18; 307(5947):178-80. PubMed ID: 6318124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ
    Scand J Gastroenterol Suppl; 1985; 117():27-38. PubMed ID: 3912963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine.
    Prince AM; Brotman B; Purcell RH; Gerin JL
    J Med Virol; 1985 Apr; 15(4):399-419. PubMed ID: 3156961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis-B vaccine. Safety criteria and non-B infection.
    Zuckerman AJ
    Lancet; 1976 Jun; 1(7974):1396-7. PubMed ID: 59027
    [No Abstract]   [Full Text] [Related]  

  • 27. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.
    Itoh Y; Takai E; Ohnuma H; Kitajima K; Tsuda F; Machida A; Mishiro S; Nakamura T; Miyakawa Y; Mayumi M
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9174-8. PubMed ID: 3466181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral type A and type B hepatitis: morphology, biology, immunology and epidemiology--a review.
    Dmochowski L
    Am J Clin Pathol; 1976 May; 65(5 Suppl):741-86. PubMed ID: 218439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
    Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
    Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Removal of hepatitis B virus infectivity from human gamma-globulin prepared by ion-exchange chromatography.
    Zolton RP; Padvelskis JV; Kaplan PM
    Vox Sang; 1985; 49(6):381-9. PubMed ID: 2418590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectious patterns of Australia antigenemia and antibodies in chimpanzees.
    Desmyter J; Liu WT; De Somer P; Mortelmans J
    Prog Immunobiol Stand; 1971; 5():81-8. PubMed ID: 4633981
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis B e antigen and antibody: detection by radioimmunoassay in chimpanzees during experimental hepatitis B.
    Tabor E; Frösner G; Deinhardt F; Gerety RJ
    J Med Virol; 1980; 6(1):91-9. PubMed ID: 7229626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus.
    Prince AM; Whalen R; Brotman B
    Vaccine; 1997 Jun; 15(8):916-9. PubMed ID: 9234547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunisation against hepatitis B in man.
    Maupas P; Goudeau A; Coursaget P; Drucker J; Bagros P
    Lancet; 1976 Jun; 1(7974):1367-70. PubMed ID: 59012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.
    Lubeck MD; Davis AR; Chengalvala M; Natuk RJ; Morin JE; Molnar-Kimber K; Mason BB; Bhat BM; Mizutani S; Hung PP
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6763-7. PubMed ID: 2570422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody to hepatitis-B-virus core in man.
    Hoofnagle JH; Gerety RJ; Barker LF
    Lancet; 1973 Oct; 2(7834):869-73. PubMed ID: 4126916
    [No Abstract]   [Full Text] [Related]  

  • 37. Adenovirus vectored vaccines.
    Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
    Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type B hepatitis: a review of current prospects for a safe and effective vaccine.
    McAuliffe VJ; Purcell RH; Gerin JL
    Rev Infect Dis; 1980; 2(3):470-92. PubMed ID: 6997970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of 10(15) chimpanzee-infectious doses of hepatitis B virus during preparation of a heat-inactivated hepatitis B vaccine.
    Lelie PN; Reesink HW; Niessen J; Brotman B; Prince AM
    J Med Virol; 1987 Nov; 23(3):289-95. PubMed ID: 2963091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against hepatitis B virus infection by immunization with hepatitis B core antigen.
    Iwarson S; Tabor E; Thomas HC; Snoy P; Gerety RJ
    Gastroenterology; 1985 Mar; 88(3):763-7. PubMed ID: 3967809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.